DealJournal posts
FeedPosted Oct 18th 2007 9:15AM by Eric Buscemi (RSS feed)
Filed under: Newspapers, Magazines, AT and T (T), , Goldman Sachs Group (GS)
MAJOR PAPERS:
OTHER PAPERS:
- The U.S. Department of Veteran Affairs has decided to sharply limit the use of GlaxoSmithKline's (NYSE: GSK) once-popular drug for Type 2 diabetes, Avandia. The decision is likely to further reduce revenue from Avandia, whose sales have dropped in the U.S. by an estimated 60% in the last five months, reported the New York Times.
- Goldman Sachs Group (NYSE: GS) said it would pay $172M for a majority stake in Indian metal castings maker Sigma Electricals and its affiliated companies, reported the Business Standard.
- A molecular diagnostic test for HPV developed by Digene, which is now part of Qiagen (NASDAQ: QGEN), has been found to be almost 40% more accurate than traditional cytology in identifying women with advanced cervical disease, according to a report published today in The New England Journal of Medicine.